Recent Clinical Trial Research for April 2025
2023 Global Forecast for Cardiac Safety Services Market (2024-2029 Outlook)-High Tech & Emerging Markets Report
Topics: Biosimilars, Biologics, Cardiovascular Devices, Clinical Trial, Cardiovascular
Regions: Global
| 2023 Global Forecast for Clinical Trial Management System Market (2024-2029 Outlook)-High Tech & Emerging Markets Report
Topics: Clinical Trial
Regions: Global
| 2023 Global Forecast for Cognitive Assessment And Training Market (2024-2029 Outlook)-High Tech & Emerging Markets Report
Topics: Clinical Trial, CNS/Neurology
Regions: Global
| 2023 Global Forecast for Efficacy Testing Market (2024-2029 Outlook)-High Tech & Emerging Markets Report
Topics: General Chemicals, Clinical Trial
Regions: Global
| 2023 Global Forecast for Electronic Clinical Outcome Assessment Solutions (2024-2029 Outlook)-High Tech & Emerging Markets Report
Topics: Clinical Trial
Regions: Global
| Respiratory Syncytial Virus (RSV) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Topics: Clinical Trial, Respiratory/Pulmonary
| Non-Alcoholic Steatohepatitis (NASH) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
Topics: Drug Discovery, Clinical Trial
| Prader-Willi Syndrome (PWS) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
Topics: Clinical Trial
| Cardiomyopathies Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031
Topics: Cardiovascular Devices, Clinical Trial, Cardiovascular
| Postherpetic Neuralgia Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
Topics: Pain, Clinical Trial
| Zollinger-Ellison Syndrome (Gastrinoma) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
Topics: Research & Development, Clinical Trial
| Vaccine Development and Production Trends, COVID-19 and Other Vaccines Pipeline
Topics: Influenza, COVID-19/Coronavirus, Public Health, Manufacturing, Packaging & Detailing, Research & Development, Vaccines, Clinical Trial, Infectious Diseases, Pandemic Vaccines
Regions: Global
| Clinical Trials - The Expanding Landscape of Regenerative Medicine
Topics: Regenerative Medicine, Clinical Trial
| Europe Clinical Trials Market - Growth, Trends, Covid-19 Impact, and Forecasts (2023 - 2028)
Topics: COVID-19/Coronavirus, Drug Discovery, Clinical Trial
Regions: Europe
| Clinical Trial Management Systems Market - Growth, Trends, Covid-19 Impact, and Forecasts (2023 - 2028)
Topics: Drug Discovery, Clinical Trial
| Superoxide Dismutase [Cu-Zn] (Superoxide Dismutase 1 or Epididymis Secretory Protein Li 44 or SOD1 or EC 1.15.1.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Pain, Sports Medicine, Drug Discovery, Clinical Trial, Rheumatology/Arthritis
| Liver Fibrosis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
Topics: Drug Discovery, Clinical Trial
| Hemophilia A (Factor VIII Deficiency) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
Topics: Blood Diseases, Drug Discovery, Clinical Trial
| Mucopolysaccharidosis II (MPS II) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Topics: Clinical Trial
| Global Veterinary CRO Market 2022-2026
Topics: Veterinary Health, Clinical Trial
Regions: Global
| Coronavirus Disease 2019 (COVID-19) Clinical Trials - Overview, Landscape, Trial using Vaccines vs. Therapeutics,and Trials Impacted by COVID-19
Topics: Research & Development, Drug Development, COVID-19/Coronavirus, Public Health, Vaccines, Drug Discovery, Clinical Trial, Pandemic Vaccines
| Coronavirus Disease 2019 (COVID-19) Vaccines - Opportunity Assessment and Forecast to 2026
Topics: Research & Development, COVID-19/Coronavirus, Public Health, Research & Development, Vaccines, Clinical Trial, Pandemic Vaccines
| Niemann-Pick Type C Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031
Topics: Generics Drugs, Research & Development, Clinical Trial
| Healthcare Cold Chain Monitoring Market: Information by Component (Hardware (Sensors, Data Loggers, Real-Time Monitoring Devices, RFID Devices, Resistance Temperature Detectors, and Others), Software (Cloud Based and On-Premises),Temperature Type (Frozen
Topics: Biologics, Sensors, RFID, Hospitals & Clinics, Cloud Computing, Warehouse & Storage, Vaccines, Biopharmaceuticals, Clinical Trial
Regions: Asia, Europe, North America, Global
| Eosinophilic Esophagitis - Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Stratergies and Forecast, 2020 - 2030
Topics: Drug Discovery, Clinical Trial
| Pharmaceutical and Healthcare Industry in Russia - Forecast and Analysis 2022
Topics: COVID-19/Coronavirus, Hospitals & Clinics, Country Overviews, Country Overviews, Manufacturing, Packaging & Detailing, Over-the-Counter Drugs, Prescription Drugs, Clinical Trial
Regions: Russia
| Gonorrhea Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: AIDS, HIV & STDs, Prescription Drugs, Drug Discovery, Clinical Trial
| Meniere Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Discovery, Clinical Trial, CNS/Neurology
| Periodontitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Discovery, Clinical Trial, Dentistry/Oral
| B-Cell Chronic Lymphocytic Leukemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Cancer Treatment, Drug Discovery, Clinical Trial, Oncology/Hematology
| Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Cancer Treatment, Drug Discovery, Clinical Trial, Oncology/Hematology
| Nasopharyngeal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Cancer Treatment, Drug Discovery, Clinical Trial, Oncology/Hematology
| Viral Conjunctivitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Discovery, Clinical Trial, Ophthalmology
| Juvenile Macular Degeneration (Stargardt Disease) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Discovery, Clinical Trial, Ophthalmology
| Leucine Rich Repeat Serine/Threonine Protein Kinase 2 (Dardarin or LRRK2 or EC 2.7.11.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Discovery, Clinical Trial
| Cell Division Protein FtsZ (ftsz) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Discovery, Clinical Trial
| Dystrophin (DMD) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Discovery, Clinical Trial
| Exportin 1 (Chromosome Region Maintenance 1 Protein Homolog or XPO1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Discovery, Clinical Trial
| Bromodomain Containing Protein 4 (Protein HUNK1 or BRD4) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Discovery, Clinical Trial
| Tyrosine Protein Kinase Mer (Proto Oncogene c Mer or Receptor Tyrosine Kinase MerTK or MERTK or EC 2.7.10.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Discovery, Clinical Trial
| Oral Mucositis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Discovery, Clinical Trial
| Duchenne Muscular Dystrophy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Discovery, Clinical Trial
| Thalassemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Blood Diseases, Drug Discovery, Clinical Trial
| Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Discovery, Clinical Trial
| Bone Marrow Transplant Rejection Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Blood Supply, Tissue Banking, Transplantation, Drug Discovery, Clinical Trial
| Candidiasis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Discovery, Clinical Trial
| African Trypanosomiasis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Discovery, Clinical Trial
| Severe Acute Respiratory Syndrome (SARS) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Discovery, Clinical Trial, Respiratory/Pulmonary
| Genital Herpes Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: AIDS, HIV & STDs, Drug Discovery, Clinical Trial
| Influenza A Virus, H3N2 Subtype Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Influenza, Drug Discovery, Clinical Trial, Infectious Diseases
|
Prev | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | Next
About MarketResearch.com
MarketResearch.com is an online aggregator selling over 400,000 market research reports, company profiles and country profiles from over 350 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.
|
